An Observational Study Validating a Score That Quantifies the Therapeutic Response to Treatment With Norditropin®
Status:
Completed
Trial end date:
2014-06-01
Target enrollment:
Participant gender:
Summary
This observational study is conducted in Europe. The aim of this observational study is to
investigate the changes in a score (GET-score) which includes quality of life, body
composition and cholesterol metabolism in patients on growth hormone treatment. The GET score
stands for: Growth hormone deficiency and Efficacy of Treatment, and is a quantitative
measurement of the efficacy of the treatment with growth hormone in adults.